Neuroone Medical Technologies Corp expected to post a loss of 20 cents a share - Earnings Preview

Neuroone Medical Technologies

08/05/2023 15:08

* Neuroone Medical Technologies Corp  NMTC.OQ   NMTC.O  is
expected to show a rise in quarterly revenue when it reports 
results on May 10 (estimated). 
    * The Eden Prairie Minnesota-based  company is expected to
report 
a 583.4% increase in revenue to $250 thousand from $36.58
thousand a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Neuroone Medical
Technologies Corp is for a loss of 20 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Neuroone
Medical
Technologies Corp is $2.63​, above​ its last closing price
of $1.41. ​​​

This summary was machine generated May 8 at 14:08 GMT.  All
figures in US dollars  unless otherwise stated